Chemotherapy is generally recommended in the middle stage of stomach cancer.
Gastric cancer is a kind of malignant tumor disease of digestive system originated from the epithelium of stomach, and its morbidity and mortality rate occupies the third place among all malignant tumor diseases, which can endanger the life, so patients need to pay attention to the treatment of the disease.
According to TNM staging, intermediate gastric cancer generally refers to stage II gastric cancer or stage III gastric cancer. According to Gastric Cancer Diagnostic and Treatment Guidelines, patients with stage II or stage III gastric cancer after radical surgery should receive postoperative adjuvant chemotherapy, which is generally recommended to use platinum-based and fluorouracil-based drugs, and the dose should be reasonably adjusted according to the doctor’s instructions during the period of adjuvant chemotherapy.
In conclusion, chemotherapy is necessary for patients with mid-stage gastric cancer, and the benefit of patients is worth affirming, but the specific chemotherapy program should be formulated after evaluation by physicians, and individuals should actively cooperate with it.